Clinical Trials Directory

Trials / Completed

CompletedNCT02657733

Comparison Study Between Nellcor Respiration Rate Technology (RRoxi) and Masimo Acoustic Respiration Rate (RRa)

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
29 (actual)
Sponsor
Oridion · Industry
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

Respiration rate is a critical vital sign that provides early detection of respiratory compromise and patient distress. Continuous monitoring of respiration rate is performed in patients under different clinical conditions, including post-surgery or different respiratory diseases. Clinician observation, pulse oximetry, and capnography are used individually or in combination to monitor ventilation during sedation and on post-surgical patients. The American Society of Anesthesiologists mandates the monitoring of respiration by measuring end tidal carbon dioxide (RRetco2) during procedural sedation and anesthesia. Other techniques for respiration rate measurement include different technologies such as acoustic respiratory rate (RRa). The aim of this study is to compare the accuracy of RRetco2 and RRa under certain respiratory conditions.

Conditions

Interventions

TypeNameDescription
DEVICERadical-7Comparison between 3 different monitors that measure respiratory rate. The participant is connected to 3 monitors at the same time. Radical-7- measures respiratory rate according to acoustic respiratory rate (RRa).
DEVICENellcor™ Bedside Respiratory Patient Monitoring SystemComparison between 3 different monitors that measure repiratory rate. The participant is connected to 3 monitors at the same time. Nellcor™ Bedside Respiratory Patient Monitoring System - measures respiratory rate according to oximetry respiration rate (RRoxi).
DEVICECapnostream 20pComparison between 3 different monitors that measure respiratory rate. The participant is connected to 3 monitors at the same time. Capnostream 20p- measures respiratory rate according to Capnography (RRetco2).

Timeline

Start date
2015-07-01
Primary completion
2015-08-01
Completion
2015-08-01
First posted
2016-01-18
Last updated
2016-11-02

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02657733. Inclusion in this directory is not an endorsement.